We are live on ! Find out more
PVI

Pura Vida Investments Portfolio holdings

AUM $14.9M
1-Year Est. Return 38.76%
This Fund
S&P 500
This Quarter Est. Return
-11.91%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$529M
AUM Growth
-$226M
Cap. Flow
-$154M
Cap. Flow %
-29.11%
Top 10 Hldgs %
40.03%
Holding
118
New
32
Increased
20
Reduced
26
Closed
35

Sector Composition

Rank Sector Weight
1 Healthcare 35.57%
2 Consumer Staples 1.71%
3 Industrials 0.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TELA icon
51
TELA Bio
TELA
$32.3M
$2.7M 0.51%
337,175
-64,841
-16% -$603K
APYX icon
52
Apyx Medical
APYX
$126M
$2.68M 0.51%
836,990
-151,604
-15% -$706K
MSOS icon
53
AdvisorShares Pure US Cannabis ETF
MSOS
$916M
$2.61M 0.49%
+328,309
New +$2.07M
LNTH icon
54
CALL
Lantheus
LNTH
$6.57B
$2.6M 0.49%
37,400
-1,900
-5% -$139K
SDGR icon
55
Schrodinger
SDGR
$1.39B
$2.49M 0.47%
87,964
+26,491
+43% +$1.07M
HUM icon
56
Humana
HUM
$46.7B
$2.43M 0.46%
+5,000
New +$2.35M
ELAN icon
57
CALL
Elanco Animal Health
ELAN
$11.1B
$2.14M 0.4%
190,200
-8,400
-4% -$97.6K
RGEN icon
58
Repligen
RGEN
$9.35B
$2.07M 0.39%
+13,000
New +$2.13M
IMDX
59
Insight Molecular Diagnostics
IMDX
$147M
$2.05M 0.39%
658,121
-23,130
-3% -$86.1K
CNMD icon
60
PUT
CONMED
CNMD
$1.48B
$2.02M 0.38%
+20,000
New +$2.3M
DXCM icon
61
DexCom
DXCM
$34.3B
$1.72M 0.32%
+18,400
New +$2.07M
TNDM icon
62
PUT
Tandem Diabetes Care
TNDM
$1.63B
$1.7M 0.32%
81,800
-21,700
-21% -$596K
HOLX
63
DELISTED
Hologic
HOLX
$1.67M 0.32%
+24,087
New +$1.82M
DCGO icon
64
PUT
DocGo
DCGO
$66.2M
$1.6M 0.3%
+300,000
New +$2.44M
PODD icon
65
Insulet
PODD
$10.1B
$1.59M 0.3%
+10,000
New +$2.24M
OM icon
66
Outset Medical
OM
$84.6M
$1.5M 0.28%
9,222
-26,983
-75% -$6.37M
OLK
67
DELISTED
Olink Holding AB (publ) American Depositary Shares
OLK
$1.31M 0.25%
88,772
-62,846
-41% -$1.05M
NSPR icon
68
InspireMD
NSPR
$40.3M
$1.16M 0.22%
356,191
+300,511
+540% +$960K
KIDS icon
69
PUT
OrthoPediatrics
KIDS
$649M
$1.09M 0.21%
+34,000
New +$1.31M
NSTG
70
CALL
DELISTED
NanoString Technologies, Inc.
NSTG
$1.02M 0.19%
+590,800
New +$1.8M
ORGO icon
71
Organogenesis Holdings
ORGO
$233M
$959K 0.18%
+301,697
New +$959K
OM icon
72
CALL
Outset Medical
OM
$84.6M
$925K 0.17%
+5,667
New +$1.34M
CUTR
73
CALL
DELISTED
Cutera, Inc.
CUTR
$903K 0.17%
150,000
+20,900
+16% +$265K
NYXH
74
Nyxoah
NYXH
$158M
$810K 0.15%
111,467
-3,348
-3% -$26.2K
SOPH icon
75
SOPHiA GENETICS
SOPH
$635M
$725K 0.14%
284,724
-324,777
-53% -$1.03M

Similar funds

Pura Vida Investments's Q3 2023 Portfolio in Review

As of Q3 2023, Pura Vida Investments held 118 positions worth $529M, down 30% from $755M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Pura Vida Investments withdrew a net $154M in Q3 2023, closing 35 positions and reducing 26 holdings. Its most notable exit was ViewRay, Inc., an estimated $3.09M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 36% of assets, up from 30% a quarter earlier, followed by Consumer Staples and Industrials.

Against the trend, Pura Vida Investments opened a new position in Kenvue worth $9.06M.

  • Pura Vida Investments's largest Q3 2023 buy was Kenvue: 451,279 shares worth $9.06M.
  • Pura Vida Investments added most to Establishment Labs in Q3 2023, an estimated $3.18M increase.
  • Pura Vida Investments's biggest Q3 2023 reduction was Outset Medical, cutting an estimated $6.37M.
  • Pura Vida Investments fully exited ViewRay, Inc. in Q3 2023, selling an estimated $3.09M.
  • Pura Vida Investments's ten largest holdings make up 40% of its $529M portfolio in Q3 2023.
  • Pura Vida Investments opened 32 new positions and closed 35 in Q3 2023.
  • Pura Vida Investments's portfolio value fell 30% quarter-over-quarter to $529M.

Based on Pura Vida Investments's 13F filing for Q3 2023, filed 14 Nov 2023.